FDA allowing use of historical controls may overcome a significant barrier and expedite pt enrollment in cartilage repair IDE trials notes Jack Farr, MD, at 2016 ICRS.
1 min read
Topics: Orthopedics
Written by Sharon O'Reilly
Founder, President and Chief Executive Officer Founder, former President & CEO, Medtech Insight, 25+ years' experience in the Medical Device industry in Sales, Marketing, Business Development, Consulting with major manufacturers (J&J, Pfizer, US Surgical), start-up companies and business intelligence providers (Medical Data International, Windhover Information)